January 24, 2011 at 12:00 PM EST
Glaxo Faces First of Many Possible Avandia Trials
Did GlaxoSmithKline's blockbuster diabetes drug Avandia cause fatal heart attacks? The first federal trial of an Avandia lawsuit began this morning in Philidelphia. As many as 50,000 more lurk in the wings. Continue reading Glaxo Faces First of Many Possible Avandia Trials Glaxo Faces First of Many Possible Avandia Trials originally appeared on DailyFinance on Mon, 24 Jan 2011 12:00:00. Filed Under: Company News , Columns , Investing , GlaxoSmithKline , Stocks in the News Permalink | Tweet this! | Comments
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here